Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
iBio (NY: IBIO)
0.4360 USD  +0.0160 (+3.81%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about iBio
 
< Previous 1 2 Next >
iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza
May 22, 2013
from PR Newswire
iBio, Inc. closes $4.2 million public offering and terminates At-the-market offering
April 29, 2013
from PR Newswire
Free Research Reports on DAL, IBIO, PHM and SWFT Issued by the Bedford Report
April 25, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
iBio, Inc. Prices $4.2 Million Public Offering
April 23, 2013
from PR Newswire
iBio, Inc. Announces Proposed Public Offering
April 22, 2013
from PR Newswire
iBio Passes Commercial Technology Transfer Milestone
April 22, 2013
from PR Newswire
iBio, Inc. receives Notice from NYSE MKT Staff that Company currently is not in compliance with an additional Continued Listing Standard
April 22, 2013
from PR Newswire
GE alliance awarded contract to design new plant-based manufacturing facility in Brazil
April 09, 2013
New facility for Bio-Manguinhos will use iBio's plant-based protein expression technology Read More
from PR Newswire
iBio Selects Proprietary Recombinant C1 Inhibitor for Clinical Development
March 26, 2013
from PR Newswire
iBio Adds to iBioModulator Portfolio and Product Pipeline
March 13, 2013
from PR Newswire
iBio Adds New Therapeutic Antibody to Its Pipeline
March 04, 2013
from PR Newswire
iBio, Inc. Receives Anticipated Notice from NYSE MKT that Company is Below Certain Continued Listing Standards
March 04, 2013
from PR Newswire
iBio And Caliber Biotherapeutics Establish License And Collaboration Relationship
February 19, 2013
from PR Newswire
iBio, Inc. Receives Approval from NYSE MKT of Compliance Plan
February 13, 2013
from PR Newswire
iBio Announces At-the-Market Equity Offering
February 01, 2013
from PR Newswire
iBio Announces New Appointment to Board of Directors and New Addition to Executive Management Team
December 21, 2012
- Seymour Flug, former chairman of Diner's Club International, joins iBio Board of Directors Read More
from PR Newswire
National Institute of Health Awards Contract to Support Use of iBio's Proprietary Technology for Improved Anthrax Vaccine
December 05, 2012
from PR Newswire
iBio, Inc. Receives Notice from NYSE MKT Staff that Company Currently is Below Certain Continued Listing Standards
November 23, 2012
from PR Newswire
New Patent Allowance Expands iBio's iBioModulator™ IP Portfolio
October 22, 2012
from PR Newswire
New Patent Expands iBio's Bio-Defense IP Portfolio
October 03, 2012
from PR Newswire
iBio to Present at the 14th Annual Rodman & Renshaw Conference
September 06, 2012
from PR Newswire
iBio, Inc. and GE Healthcare form new global alliance
July 26, 2012
Companies to commercialize plant-based technologies for biopharmaceutical and vaccine manufacture Read More
from PR Newswire
iBio Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform
June 18, 2012
from PR Newswire
Broad Patent Protection Granted for iBio Immunomodulator
May 08, 2012
from PR Newswire
iBio Announces Further Positive Results With iBioModulator™ Platform
April 26, 2012
from PR Newswire
OPHC, BBDA and IBIO are the Stocks to Watch for April 19th from OTCPicks.com
April 19, 2012
from EmailWire.Com Press Releases
iBio to Present at the Wells Fargo Securities 2012 Healthcare Conference
April 16, 2012
from PR Newswire
iBio Announces Production of Biosimilar Palivizumab with its iBioLaunch™ Technology
April 10, 2012
from PR Newswire
New Patent Broadens iBio's Proprietary Biologics Platform
April 04, 2012
from PR Newswire
Vaccine Applications of iBio's Proprietary Lichenase Technology Reported at International Conference
March 27, 2012
from PR Newswire
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here